Parnell today announced the launch of Pentobarbital Sodium and Phenytoin Sodium Euthanasia Solution, a Class III controlled ...
The global epilepsy drugs market is poised for robust growth, estimated to increase from US$ 8.29 billion in 2025 to US$ ...
Alembic Pharmaceuticals has received approval from the United States Food and Drug Administration for its generic drug, ...
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine Orally Disintegrating Tablets USP, 25 mg, ...
Lamotrigine is primarily used to treat seizures. According to IQVIA data, the estimated market size for the product is $27 ...
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug ...
Alembic Pharma receives US FDA approval for lamotrigine orally disintegrating tablets USP, 25 mg, 50 mg, 100 mg & 200 mg: Our Bureau, Mumbai Thursday, February 26, 2026, 14:15 Hrs ...
INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults ...
Vitamin D isn’t the only bone builder you need to look out for.
KalVista Pharmaceuticals, Inc. today announced that the newly published International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema recommends EKTERLY® ...
Freedom Bank Kazakhstan, a part of Freedom Holding Corp., a NASDAQ-listed finance and technology group, received the award in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results